Cancer chemoprevention by connexins

Cancer and Metastasis Reviews

Volumn 21, Issue 3-4, 2002, Pages 199-216

  Vine, Alex L ^a   Bertram, John S ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Cancer; Carcinogenesis; Connexins; Gap junctions; Growth control; Human

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIC AMP; GAP JUNCTION PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR PROMOTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOPLASM; GAP JUNCTION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR PROMOTION; XENOGRAFT;

ANIMALS; CELL COMMUNICATION; CONNEXINS; HUMANS; NEOPLASMS; RISK FACTORS;

EID: 0036955065     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021250624933     Document Type: Review

References (116)

1. Beyer EC, Paul DL, Goodenough DA: Connexin family of gap junction proteins. J Membr Biol 116: 187-194, 1990
2. Kumar NM: Molecular biology of the interactions between connexins. Novartis Found Symp 219: 6-16, 1999
3. Loewenstein WR, Kanno Y: Intercellular communication and the control of tissue growth: Lack of communication between cancer cells. Nature 209: 1248-1249, 1966
4. Azarnia R, Loewenstein WR: Intercellular communication and the control of growth: XI. Alteration of junctional permeability by the src gene in a revertant cell with normal cytoskeleton. J Membr Biol 82: 207-212, 1984
5. Loewenstein WR: Junctional intercellular communication and the control of growth. Biochim Biophys Acta 560: 1-65, 1979
6. Reznikoff CA, Bertram JS, Brankow DW, Heidelberger C: Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 33: 2339-2349, 1973
7. Merriman R, Bertram JS: Reversible inhibition by retinoids of 3-methylcholanthrene-induced neoplastic transformation in C3H10T1/2 cells. Cancer Res 39: 1661-1666, 1979
8. Mordan LJ, Bergin LM, Budnick JL, Meegan R, Bertram JS: Isolation of methylcholanthrene-initiated C3H/10T1/2 cells by inhibiting neoplastic progression with retinyl acetate. Carcinogenesis 3(3): 279-285, 1982
9. Mordan LJ, Martner JE, Bertram JS: Quantitative neoplastic transformation of C3H/10T fibroblasts: Dependence upon the size of the initiated cell colony at confluence. Cancer Res 43: 4062-4067, 1983
10. Bertram JS: Modulation of cellular interactions between C3H/10T1/2 cells and their transformed counterparts by phosphodiestrase inhibitors. Cancer Res 39: 3502-3508, 1979
11. Bertram JS, Faletto MB: Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3′:5′-phosphodiesterase. Cancer Res 45: 1946-1952, 1985
12. Mehta PP, Bertram JS, Loewenstein WR: Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44: 187-196, 1986
13. Hossain MZ, Wilkens LR, Mehta PP, Loewenstein WR, Bertram JS: Enhancement of gap junctional communication by retinoids correlates with their ability to inhibit neoplastic transformation. Carcinogenesis 10: 1743-1748, 1989
14. Hossain MZ, Bertram JS: Retinoids suppress proliferation, induce cell spreading, and up-regulate connexin 43 expression only in postconfluent 10T1/2 cells: Implications for the role of gap junctional communication. Cell Growth Differ 5: 1253-1261, 1994
15. Boutwell RK, Verma AK, Ashendel CL, Astrup E: Mouse skin: A useful model system for studying the mechanism of chemical carcinogenesis. Carcinog Compr Surv 7: 1-12, 1982
16. Mordan LJ, Bertram JS: Retinoid effects on cell-cell interactions and growth characteristics of normal and carcinogen-treated C3H/10T1/2 cells. Cancer Res 43: 567-571, 1983
17. Trosko JE, Ruch RJ: Cell-cell communication in carcinogenesis. Frontiers Biosci 3: 208-236, 1998
18. Ruch RJ, Klaunig JE, Pereira MA: Inhibition of intercellular communication between mouse hepatocytes by tumor promoters. Toxicol Appl Pharmacol [VWO] 87: 111-120, 1987
19. Moennikes O, Buchmann A, Romualdi A, Ott T, Werringloer J, Willecke K, Schwarz M: Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin 32-null mice. Cancer Res 60: 5087-5091, 2000
20. Bruzzone R, White TW, Paul DL: Connections with connexins: The molecular basis of direct intercellular signaling. Eur J Biochem 238: 1-27, 1996
21. Neveu M, Bertram JS: Gap junctions and neoplasia. In: Hertzberg EL, Bittar EE (eds) Gap Junctions, JAI Press, Greenwich, CT, 2000, pp 221-262
22. Weinberg RA: Tumor suppressor genes. Science 254: 1138-1146, 1991
23. King TJ, Fukushima LH, Hieber AD, Shimabukuro KA, Sakr WA, Bertram JS: Reduced levels of connexin 43 in cervical dysplasia: Inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression. Carcinogenesis 21: 1097-1109, 2000
24. Huang RP, Hossain MZ, Sehgal A, Boynton AL: Reduced connexin 43 expression in high-grade human brain glioma cells. J Surg Oncol 70: 21-24, 1999
25. Soroceanu L, Manning TJ Jr, Sontheimer H: Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 33: 107-117, 2001
26. Aronica E, Gorter JA, Jansen GH, Leenstra S, Yankaya B, Troost D: Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol (Berl) 101: 449-459, 2001
27. Habermann H, Ray V, Habermann W, Prins GS: Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer. J Urol 167: 655-660, 2002
28. Hossain MZ, Jagdale AB, Ao P, LeCiel C, Huang RP, Boynton AL: Impaired expression and posttranslational processing of connexin 43 and downregulation of gap junctional communication in neoplastic human prostate cells. Prostate 38: 55-59, 1999
29. Robertson KD, Jones PA: DNA methylation: Past, present and future directions. Carcinogenesis 21: 461-467, 2000
30. Piechocki MP, Burk RD, Ruch RJ: Regulation of connexin 32 and connexin 43 gene expression by DNA methylation in rat liver cells. Carcinogenesis 20: 401-406, 1999
31. Lee SW, Tomasetto C, Sager R: Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA 88: 2825-2829, 1991
32. Tan Lw LW, Bianco T, Dobrovic A: Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer. Carcinogenesis 23: 231-236, 2002
33. King TJ, Fukushima LH, Donlon TA, Hieber AD, Shimabukuro KA, Bertram JS: Correlation between growth control, neoplastic potential and endogenous connexin 43 expression in HeLa cell lines: Implications for tumor progression. Carcinogenesis 21: 311-315, 2000
34. Krutovskikh V, Yamasaki H: Connexin gene mutations in human genetic diseases. Mutat Res 462: 197-207, 2000
35. Temme A, Buchmann A, Gabriel HD, Nelles E, Schwarz M, Willecke K: High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin 32. Curr Biol 7: 713-716, 1997
36. Lampe PD, Lau AF: Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 384: 205-215, 2000
37. Saez JC, Martinez AD, Branes MC, Gonzalez HE: Regulation of gap junctions by protein phosphorylation. Braz J Med Biol Res 31: 593-600, 1998
38. Rivedal E, Opsahl H: Role of PKC and MAP kinase in EGF- and TPA-induced connexin 43 phosphorylation and inhibition of gap junction intercellular communication in rat liver epithelial cells. Carcinogenesis 22: 1543-1550, 2001
39. src-mediated phosphorylation of connexin 43, a gap junction protein. J Biol Chem 270: 12751-12761, 1995
40. Nose A, Tsuji K, Takeichi M: Localization of specificity determining sites in cadherin cell adhesion molecules. Cell 61: 147-155, 1990
41. Mehta PP, Yamamoto M, Rose B: Transcription of the gene for the gap junctional protein connexin 43 and expression of functional cell-to-cell channels are regulated by cAMP. Mol Biol Cell 3: 839-850, 1992
42. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H: Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769, 1995
43. Mehta PP, Bertram JS, Loewenstein WR: The actions of retinoids on cellular growth correlate with their actions on gap junctional communication. J Cell Biol 108: 1053-1065, 1989
44. Mehta PP, Hotz Wagenblatt A, Rose B, Shalloway D, Loewenstein WR: Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growth. J Membr Biol 124: 207-225, 1991
45. King TJ, Fukushima LH, Yasui, Lampe PD, Bertram JS: Inducible expression of the gap junction protein connexin43 decreases the neoplastic potential of HT-1080 human fibrosarcoma cells in vitro and in vivo. Mol Carcin In press 2003
46. Giepmans BN, Verlaan I, Hengeveld T, Janssen H, Calafat J, Falk MM, Moolenaar WH: Gap junction protein connexin-43 interacts directly with microtubules. Curr Biol 11: 1364-1368, 2001
47. Toyofuku T, Yabuki M, Otsu K, Kuzuya T, Hori M, Tada M: Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. J Biol Chem 273: 12725-12731, 1998
48. Xu X, Li WE, Huang GY, Meyer R, Chen T, Luo Y, Thomas MP, Radice GL, Lo CW: Modulation of mouse neural crest cell motility by N-cadherin and connexin 43 gap junctions. J Cell Biol 154: 217-230, 2001
49. Bertram JS, Bertram BB, Janik P: Inhibition of neoplastic cell growth by quiescent cells is mediated by serum concentration and cAMP phosphodiesterase inhibitors. J Supramol Struct Cell Biochem 18: 515-538, 1982
50. Janik P, Assaf A, Bertram JS: Inhibition of growth of primary and metastatic Lewis lung carcinoma cells by the phosphodiesterase inhibitor isobutylmethylxanthine. Cancer Res 40: 1950-1054, 1980
51. Ito A, Katoh F, Kataoka TR, Okada M, Tsubota N, Asada H, Yoshikawa K, Maeda S, Kitamura Y, Yamasaki H, Nojima H: A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest 105: 1189-1197, 2000
52. Bechberger JF, Khoo NSK, Naus CCG: Analysis of connexin 43 expression under the control of a metallothionein promoter. Cell Growth Differ 7: 1403-1413, 1996
53. Singh MV, Bhatnagar R, Malhotra SK: Inhibition of connexin 43 synthesis by antisense RNA in rat glioma cells. Cytobios 91: 103-123, 1997
54. Mesnil M, Krutovskikh V, Piccoli C, Elfgang C, Traub O, Willecke K, Yamasaki H: Negative growth control of HeLa cells by connexin genes: Connexin species specificity. Cancer Res 55: 629-639, 1995
55. Goldberg GS, Bechberger IF, Tajima Y, Merritt M, Omori Y, Gawinowicz MA, Narayanan R, Tan Y, Sanai Y, Yamasaki H, Naus CC, Tsuda H, Nicholson BJ: Connexin 43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. Cancer Res 60: 6018-6026, 2000
56. Ek-Vitorín JF, Calero G, Morley GE, Coombs W, Taffet SM, Delmar M: pH regulation of connexin 43: Molecular analysis of the gating particle. Biophys J 71: 1273-1284, 1996
57. Omori Y, Yamasaki H: Gap junction proteins connexin 32 and connexin 43 partially acquire growth-suppressive function in HeLa cells by deletion of their C-terminal tails. Carcinogenesis 20: 1913-1918, 1999
58. De Feijter-Rupp HL, Hayashi T, Kalimi GH, Edwards P, Redpath JL, Chang CC, Stanbridge EJ, Trosko JE: Restored gap junctional communication in non-tumorigenic HeLanormal human fibroblast hybrids. Carcinogenesis 19: 747-754, 1998
59. Krutovskikh VA, Yamasaki H, Tsuda H, Asamoto M: Inhibition of intrinsic gap-junction intercellular communication and enhancement of tumorigenicity of the rat bladder carcinoma cell line BC31 by a dominant-negative connexin 43 mutant. Mol Carcinog 23: 254-261, 1998
60. Zhu D, Caveney S, Kidder GM, Naus CC: Transfection of C6 glioma cells with connexin 43 cDNA: Analysis of expression, intercellular coupling, and cell proliferation. Proc Natl Acad Sci USA 88: 1883-1887, 1991
61. Naus CC, Elisevich K, Zhu D, Belliveau DJ, Del Maestro RF: In vivo growth of C6 glioma cells transfected with connexin 43 cDNA. Cancer Res 52: 4208-4213, 1992
62. Zhu D, Kidder GM, Caveney S, Naus CC: Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein. Proc Natl Acad Sci USA 89: 10218-10221, 1992
63. Bradshaw SL, Naus CCG, Zhu D, Kidder GM, D'Ercole AJ, Han VKM: Alterations in the synthesis of insulin-like growth factor binding proteins and insulin-like growth factors in rat C6 glioma cells transfected with a gap junction connexin 43 cDNA. Regulatory Peptides 48: 99-112, 1993
64. Ruffin MT, Lancaster WD: Clinical models of chemoprevention for cervical cancer. Hematol Oncol Clin North Am 12: 1115-1134, 1998
65. Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL: Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 58: 5089-5096, 1998
66. Bond SL, Bechberger JF, Khoo NK, Naus CC: Transfection of C6 glioma cells with connexin 32: The effects of expression of a nonendogenous gap junction protein. Cell Growth Differ 5: 179-186, 1994
67. Goldberg GS, Lampe PD, Nicholson BJ: Selective transfer of endogenous metabolites through gap junctions composed of different connexins. Nat Cell Biol 1: 457-459, 1999
68. Zhu D, Kidder GM, Caveney S, Naus CCG: Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein. Proc Natl Acad Sci USA 89: 10218-10221, 1992
69. Rose B, Mehta PP, Loewenstein WR: Gap-junction protein gene suppresses tumorigenicity. Carcinogenesis 14: 1073-1075, 1993
70. Chen SC, Pelletier DB, Ao P, Boynton AL: Connexin 43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ 6: 681-690, 1995
71. Yano T, Hernandez-Blazquez FJ, Omori Y, Yamasaki H: Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32. Carcinogenesis 22: 1593-1600, 2001
72. Yano T, Yamasaki H: Regulation of cellular invasion and matrix metalloproteinase activity in HepG2 cell by connexin 26 transfection. Mol Carcinog 31: 101-109, 2001
73. Duflot-Dancer A, Mesnil M, Yamasaki H: Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene 15: 2151-2158, 1997
74. Omori Y, Yamasaki H: Mutated connexin 43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin 43 in a dominant-negative manner. Int J Cancer 78: 446-453, 1998
75. Gabriel HD, Jung D, Butzler C, Temme A, Traub O, Winterhager E, Willecke K: Transplacental uptake of glucose is decreased in embryonic lethal connexin 26-deficient mice. J Cell Biol 140: 1453-1461, 1998
76. Simpson I, Rose B, Loewenstein WR: Size limit of molecules permeating the junctional membrane channels. Science 195: 294-296, 1977
77. Bevans CG, Kordel M, Rhee SK, Harris AL: Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules. J Biol Chem 273: 2808-2816, 1998
78. Goldberg GS, Lampe PD, Sheedy D, Stewart CC, Nicholson BJ, Naus CC: Direct isolation and analysis of endogenous transjunctional ADP from Cx43 transfected C6 glioma cells. Exp Cell Res 239: 82-92, 1998
79. Fletcher WH, Byus CV, Walsh DA: Receptor-mediated action without receptor occupancy: A function for cell-cell communication in ovarian follicles. Adv Exp Med Biol 219: 299-323, 1987
80. Granot I, Dekel N: Cell-to-cell communication in the ovarian follicle: Developmental and hormonal regulation of the expression of connexin 43. Hum Reprod 13(Suppl 4): 85-97, 1998
81. Simon AM, Goodenough DA, Li E, Paul DL: Female infertility in mice lacking connexin 37. Nature 385: 525-529, 1997
82. Berridge MJ: The versatility and complexity of calcium signalling. Novartis Found Symp 239: 52-64, 2001
83. Fry T, Evans JH, Sanderson MJ: Propagation of intercellular calcium waves in C6 glioma cells transfected with connexins 43 or 32. Microsc Res Tech 52: 289-300, 2001
84. Toyofuku T, Yabuki M, Otsu K, Kuzuya T, Hori M, Tada M: Intercellular calcium signaling via gap junction in connexin-43-transfected cells. J Biol Chem 273: 1519-1528, 1998
85. Cotrina ML, Lin JHC, Alves-Rodrigues A, Liu S, Li J, Azmi-Ghadimi H, Kang J, Naus CCG, Nedergaard M: Connexins regulate calcium signaling by controlling ATP release. Proc Nat Acad Sci USA 95: 15735-15740, 1998
86. Jorgensen NR, Geist ST, Civitelli, R, Steinberg TH: ATP-and gap junction-dependent intercellular calcium signaling in osteoblastic cells. J Cell Biol 139: 497-506, 1997
87. Moon RC, Pritchard JF, Mehta RG, Nomides CT, Thomas CF, Dinger NM: Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor. Carcinogenesis 10: 1645-1649, 1989
88. Giepmans BNG, Moolenaar WH: The gap junction protein connexin 43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr Biol 8: 931-934, 1998
89. Kojima T, Kokai Y, Chiba H, Yamamoto M, Mochizuki Y, Sawada N: Cx32 but not Cx26 is associated with tight junctions in primary cultures of rat hepatocytes. Exp Cell Res 263: 193-201, 2001
90. Prowse DM, Cadwallader GP, Pitts JD: E-cadherin expression can alter the specificity of gap junction formation. Cell Biol Int 21: 833-843, 1997
91. Barker RJ, Price RL, Gourdie RG: Increased association of ZO-1 with connexin 43 during remodeling of cardiac gap junctions. Circ Res 90: 317-324, 2002
92. Yano T, Yamasaki H: Regulation of cellular invasion and matrix metalloproteinase activity in HepG2 cell by connexin 26 transfection. Mol Carcinog 31: 101-109, 2001
93. Ai ZW, Fischer A, Spray DC, Brown, AMC, Fishman GI: Wnt-1 regulation of connexin 43 in cardiac myocytes. J Clin Invest 105: 161-171, 2000
94. Bullions LC, Levine AJ: The role of beta-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol 10: 81-87, 1998
95. Giarre M, Semenov MV, Brown AM: Wnt signaling stabilizes the dual-function protein beta-catenin in diverse cell types. Ann NY Acad Sci 857: 43-55, 1998
96. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW: Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130-1134, 1998
97. Su L-K, Vogelstein B, Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737, 1993
98. Papkoff J, Rubinfeld B, Schryver B, Polakis P: Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol Cell Biol 16: 2128-2134, 1996
99. Sakanaka C, Sun TQ, Williams LT: New steps in the Wnt/beta-catenin signal transduction pathway. Recent Prog Horm Res 55: 225-236, 2000
100. Meyer RA, Cohen MF, Recalde S, Zakany J, Bell SM, Scott WJ Jr, Lo CW: Developmental regulation and asymmetric expression of the gene encoding Cx43 gap junctions in the mouse limb bud. Develop Genet 21: 290-300, 1997
101. Makiyama N, Matsui H, Tsuji H, Ichimura K: Attachment and invasion of high- and low-metastatic clones of RCT sarcoma in a three-dimensional culture system. Clin Exp Metastasis 9: 411-425, 1991
102. Moorby CD: A connexin 43 mutant lacking the carboxyl cytoplasmic domain inhibits both growth and motility of mouse 3T3 fibroblasts. Mol Carcinog 28: 23-30, 2000
103. Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, Advani S, Yu J, Perbal B, Weichselbaum RR: Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54: 293-299, 2001
104. Cesen-Cummings K, Fernstrom MJ, Malkinson AM, Ruch RJ: Frequent reduction of gap junctional intercellular communication and connexin 43 expression in human and mouse lung carcinoma cells. Carcinogenesis 19: 61-67, 1998
105. Tomai E, Brownell HL, Tufescu TV, Reid K, Campling BG, Raptis L: Gap junctional communication in cultured human lung carcinoma cells. Lung Cancer 23: 223-231, 1999
106. Jinn Y, Ichioka M, Marumo F: Expression of connexin 32 and connexin 43 gap junction proteins and E-cadherin in human lung cancer. Cancer Lett 127: 161-169, 1998
107. El Bayoumy K, Rose DP, Papanikolaou N, Leszczynska J, Swamy MV, Rao CV: Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: Impact of an organoselenium compound on growth regulation. Int J Oncol 20: 557-561, 2002
108. Saito T, Nishimura M, Kudo R, Yamasaki H: Suppressed gap junctional intercellular communication in carcinogenesis of endometrium. Int J Cancer 93: 317-323, 2001
109. Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon A-M, Mesnil M, Berger F, Partensky C, Yamasaki H: Altered homologous and heterologous Gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 56: 87-94, 1994
110. Yamasaki H, Omori Y, Zaidan-Dagli ML, Mironov N, Mesnil M, Krutovskikh V: Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis. Cancer Detect Prev 23: 273-279, 1999
111. Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA: Deficiency of connexin 43 gap junctions is an independent marker for breast tumors. Cancer Res 59: 4104-4110, 1999
112. Wilgenbus KK, Kirkpatrick CJ, Knuechel R, Willecke K, Traub O: Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer 51: 522-529, 1992
113. Lee SW, Tomasetto C, Sager R: Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA 88: 2825-2829, 1991
114. Scherer SS, Bone LJ, Deschenes SM, Abel A, Balice-Gordon RJ, Fischbeck KH: The role of the gap junction protein connexin 32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease. Novartis Found Symp 219: 175-185, 1999
115. Mehta P, Perez-Stable C, Nadji M, Mian M, Asotra K, Roos BA: Suppression of human prostate cancer cell growth by forced expression of connexin genes. Develop Genet 24: 91-110, 1999
116. Bertram JS: Cellular communication via gap junctions. Sci Med April: 32-41, 2000